Brief: Biophytis SA Says Half-Year Loss Has Been Significantly Reduced, From EUR 12.4 Million At 30 June 2022 To EUR 7.8 Million At 30 June 2023
27/09/2023 22:16
Sept 27 (Reuters) - Biophytis SA ALBPS.PA :
* HALF-YEAR LOSS HAS BEEN SIGNIFICANTLY REDUCED, FROM EUR
12.4
MILLION AT 30 JUNE 2022 TO EUR 7.8 MILLION AT 30 JUNE 2023
Source text for Eikon: ID:nEQ7sWx9ka
Further company coverage: ALBPS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon